Cerity Partners LLC Sells 4,925 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

Cerity Partners LLC lessened its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 54.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,132 shares of the biotechnology company's stock after selling 4,925 shares during the period. Cerity Partners LLC's holdings in Axon Enterprise were worth $2,173,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Fourth Dimension Wealth LLC acquired a new position in shares of Axon Enterprise during the fourth quarter valued at about $30,000. Bartlett & CO. Wealth Management LLC grew its holdings in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after buying an additional 33 shares during the last quarter. Catalyst Capital Advisors LLC acquired a new position in shares of Axon Enterprise during the first quarter valued at about $32,000. Alpine Bank Wealth Management purchased a new position in Axon Enterprise during the first quarter worth about $40,000. Finally, Elequin Capital LP purchased a new position in Axon Enterprise during the fourth quarter worth about $46,000. Institutional investors own 79.08% of the company's stock.

Analyst Ratings Changes

Several research firms recently weighed in on AXON. JPMorgan Chase & Co. boosted their price target on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a report on Thursday. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Barclays boosted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Wolfe Research started coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They issued an "outperform" rating on the stock. Finally, Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the stock an "overweight" rating in a report on Friday, July 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of "Moderate Buy" and a consensus target price of $763.75.

Insider Buying and Selling

In other news, CRO Cameron Brooks sold 3,000 shares of Axon Enterprise stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $740.76, for a total value of $2,222,280.00. Following the completion of the transaction, the executive owned 19,447 shares in the company, valued at approximately $14,405,559.72. This trade represents a 13.36% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 9,905 shares of Axon Enterprise stock in a transaction dated Wednesday, May 21st. The shares were sold at an average price of $738.03, for a total value of $7,310,187.15. Following the completion of the transaction, the president owned 298,809 shares of the company's stock, valued at $220,530,006.27. The trade was a 3.21% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock worth $30,500,428 over the last 90 days. 4.40% of the stock is owned by insiders.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $756.09 on Friday. The business's 50 day moving average price is $763.54 and its 200 day moving average price is $645.97. The firm has a market cap of $58.86 billion, a P/E ratio of 182.63, a P/E/G ratio of 87.03 and a beta of 1.29. Axon Enterprise, Inc has a 52 week low of $279.02 and a 52 week high of $830.21. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same period in the prior year, the company posted $1.15 EPS. The business's quarterly revenue was up 31.3% on a year-over-year basis. On average, sell-side analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.